In total , 50 patients were randomized and included in outcome and adverse-event analysis ; 46 patients ( 8.20.5 years ; 24.91.9 kg ; meanSEM ) completed the protocol and were fully analyzed ( 24 and 22 subjects in the HSL and RL groups , respectively ) .